Nortriptyline
Internal ID | e736713e-e8b2-489f-baae-264b3f2d3b63 |
Taxonomy | Benzenoids > Dibenzocycloheptenes |
IUPAC Name | N-methyl-3-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,11,13-hexaenylidene)propan-1-amine |
SMILES (Canonical) | CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31 |
SMILES (Isomeric) | CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31 |
InChI | InChI=1S/C19H21N/c1-20-14-6-11-19-17-9-4-2-7-15(17)12-13-16-8-3-5-10-18(16)19/h2-5,7-11,20H,6,12-14H2,1H3 |
InChI Key | PHVGLTMQBUFIQQ-UHFFFAOYSA-N |
Popularity | 8,184 references in papers |
Molecular Formula | C19H21N |
Molecular Weight | 263.40 g/mol |
Exact Mass | 263.167399674 g/mol |
Topological Polar Surface Area (TPSA) | 12.00 Ų |
XlogP | 4.50 |
Atomic LogP (AlogP) | 3.83 |
H-Bond Acceptor | 1 |
H-Bond Donor | 1 |
Rotatable Bonds | 3 |
Aventyl |
72-69-5 |
Desitriptilina |
Noramitriptyline |
Lumbeck |
Desmethylamitriptyline |
Noritren |
Sensaval |
Ateben |
Avantyl |
There are more than 10 synonyms. If you wish to see them all click here. |
![2D Structure of Nortriptyline 2D Structure of Nortriptyline](https://plantaedb.com/storage/docs/compounds/2023/07/nortriptyline.jpg)
Target | Value | Probability (raw) | Probability (%) |
---|---|---|---|
Human Intestinal Absorption | + | 0.9947 | 99.47% |
Caco-2 | + | 0.9406 | 94.06% |
Blood Brain Barrier | + | 1.0000 | 100.00% |
Human oral bioavailability | + | 0.9714 | 97.14% |
Subcellular localzation | Lysosomes | 0.8521 | 85.21% |
OATP2B1 inhibitior | - | 0.8854 | 88.54% |
OATP1B1 inhibitior | + | 0.9369 | 93.69% |
OATP1B3 inhibitior | + | 0.9467 | 94.67% |
MATE1 inhibitior | - | 1.0000 | 100.00% |
OCT2 inhibitior | + | 0.9000 | 90.00% |
BSEP inhibitior | + | 0.8594 | 85.94% |
P-glycoprotein inhibitior | + | 0.6050 | 60.50% |
P-glycoprotein substrate | - | 0.7548 | 75.48% |
CYP3A4 substrate | + | 0.5857 | 58.57% |
CYP2C9 substrate | - | 1.0000 | 100.00% |
CYP2D6 substrate | + | 0.6766 | 67.66% |
CYP3A4 inhibition | - | 0.7665 | 76.65% |
CYP2C9 inhibition | - | 0.9070 | 90.70% |
CYP2C19 inhibition | - | 0.9025 | 90.25% |
CYP2D6 inhibition | + | 0.8932 | 89.32% |
CYP1A2 inhibition | + | 0.9107 | 91.07% |
CYP2C8 inhibition | - | 0.9375 | 93.75% |
CYP inhibitory promiscuity | - | 0.5194 | 51.94% |
UGT catelyzed | - | 0.0000 | 0.00% |
Carcinogenicity (binary) | - | 0.9200 | 92.00% |
Carcinogenicity (trinary) | Non-required | 0.7865 | 78.65% |
Eye corrosion | - | 0.9911 | 99.11% |
Eye irritation | - | 0.9541 | 95.41% |
Skin irritation | - | 0.5325 | 53.25% |
Skin corrosion | - | 0.6365 | 63.65% |
Ames mutagenesis | - | 0.8900 | 89.00% |
Human Ether-a-go-go-Related Gene inhibition | + | 0.7128 | 71.28% |
Micronuclear | - | 0.7300 | 73.00% |
Hepatotoxicity | - | 0.5750 | 57.50% |
skin sensitisation | - | 0.5928 | 59.28% |
Respiratory toxicity | + | 0.8111 | 81.11% |
Reproductive toxicity | + | 0.5444 | 54.44% |
Mitochondrial toxicity | + | 0.9000 | 90.00% |
Nephrotoxicity | - | 0.5843 | 58.43% |
Acute Oral Toxicity (c) | III | 0.8000 | 80.00% |
Estrogen receptor binding | + | 0.6650 | 66.50% |
Androgen receptor binding | + | 0.7438 | 74.38% |
Thyroid receptor binding | + | 0.7195 | 71.95% |
Glucocorticoid receptor binding | - | 0.6015 | 60.15% |
Aromatase binding | - | 0.5000 | 50.00% |
PPAR gamma | + | 0.8450 | 84.50% |
Honey bee toxicity | - | 0.9381 | 93.81% |
Biodegradation | - | 0.8750 | 87.50% |
Crustacea aquatic toxicity | + | 0.7200 | 72.00% |
Fish aquatic toxicity | + | 0.9456 | 94.56% |
Proven Targets:
CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
---|---|---|---|---|---|
CHEMBL223 | P25100 | Alpha-1d adrenergic receptor |
273 nM |
IC50 |
via CMAUP
|
CHEMBL1867 | P08913 | Alpha-2a adrenergic receptor |
732 nM |
IC50 |
via CMAUP
|
CHEMBL1942 | P18089 | Alpha-2b adrenergic receptor |
94 nM |
IC50 |
via CMAUP
|
CHEMBL1916 | P18825 | Alpha-2c adrenergic receptor |
203 nM |
IC50 |
via CMAUP
|
CHEMBL4096 | P04637 | Cellular tumor antigen p53 |
19952.6 nM 19952.6 nM |
Potency Potency |
via CMAUP
via CMAUP |
CHEMBL3356 | P05177 | Cytochrome P450 1A2 |
25118.86 nM 7943.28 nM |
AC50 AC50 |
via CMAUP
via CMAUP |
CHEMBL3622 | P33261 | Cytochrome P450 2C19 |
3000 nM |
IC50 |
via CMAUP
|
CHEMBL3721 | P10632 | Cytochrome P450 2C8 |
49900 nM |
Ki |
PMID: 16248836
|
CHEMBL289 | P10635 | Cytochrome P450 2D6 |
2600 nM 2300 nM |
IC50 IC50 |
PMID: 15481972
PMID: 12502361 |
CHEMBL340 | P08684 | Cytochrome P450 3A4 |
12589.3 nM 15848.9 nM 12589.3 nM 15848.9 nM |
Potency Potency Potency Potency |
via CMAUP
via CMAUP via CMAUP via CMAUP |
CHEMBL2056 | P21728 | Dopamine D1 receptor |
539 nM |
IC50 |
via CMAUP
|
CHEMBL234 | P35462 | Dopamine D3 receptor |
179 nM |
IC50 |
via CMAUP
|
CHEMBL238 | Q01959 | Dopamine transporter |
1678 nM |
IC50 |
via CMAUP
|
CHEMBL231 | P35367 | Histamine H1 receptor |
50 nM |
IC50 |
via CMAUP
|
CHEMBL1941 | P25021 | Histamine H2 receptor |
2334 nM |
IC50 |
via CMAUP
|
CHEMBL5514 | P42858 | Huntingtin |
25118.9 nM |
Potency |
via CMAUP
|
CHEMBL216 | P11229 | Muscarinic acetylcholine receptor M1 |
82 nM |
IC50 |
via CMAUP
|
CHEMBL211 | P08172 | Muscarinic acetylcholine receptor M2 |
347 nM |
IC50 |
via CMAUP
|
CHEMBL245 | P20309 | Muscarinic acetylcholine receptor M3 |
171 nM |
IC50 |
via CMAUP
|
CHEMBL1821 | P08173 | Muscarinic acetylcholine receptor M4 |
95 nM |
IC50 |
via CMAUP
|
CHEMBL2035 | P08912 | Muscarinic acetylcholine receptor M5 |
27 nM |
IC50 |
via CMAUP
|
CHEMBL222 | P23975 | Norepinephrine transporter |
3.21 nM |
IC50 |
via CMAUP
|
CHEMBL1293235 | P02545 | Prelamin-A/C |
35.5 nM 35.5 nM 251.2 nM |
Potency Potency Potency |
via Super-PRED
via CMAUP via CMAUP |
CHEMBL2842 | P42345 | Serine/threonine-protein kinase mTOR |
23280.9 nM 23280.9 nM 23280.9 nM |
Potency Potency Potency |
via CMAUP
via CMAUP via CMAUP |
CHEMBL224 | P28223 | Serotonin 2a (5-HT2a) receptor |
51 nM |
IC50 |
via CMAUP
|
CHEMBL1833 | P41595 | Serotonin 2b (5-HT2b) receptor |
136 nM |
IC50 |
via CMAUP
|
CHEMBL225 | P28335 | Serotonin 2c (5-HT2c) receptor |
16 nM |
IC50 |
via CMAUP
|
CHEMBL3371 | P50406 | Serotonin 6 (5-HT6) receptor |
554 nM 214 nM |
IC50 Ki |
via CMAUP
via Super-PRED |
CHEMBL228 | P31645 | Serotonin transporter |
13 nM |
IC50 |
via CMAUP
|
CHEMBL1293256 | P40225 | Thrombopoietin |
12589.3 nM 12589.3 nM |
Potency Potency |
via CMAUP
via CMAUP |
CHEMBL1963 | P16473 | Thyroid stimulating hormone receptor |
7943.3 nM 7943.3 nM |
Potency Potency |
via CMAUP
via CMAUP |
CHEMBL2041 | P07949 | Tyrosine-protein kinase receptor RET |
5000 nM 1500 nM |
IC50 IC50 |
via CMAUP
via CMAUP |
Predicted Targets (via Super-PRED):
CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
---|---|---|---|---|
CHEMBL2581 | P07339 | Cathepsin D | 94.97% | 98.95% |
CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 94.02% | 91.11% |
CHEMBL1951 | P21397 | Monoamine oxidase A | 91.66% | 91.49% |
CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 89.07% | 96.09% |
CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 86.05% | 95.56% |
CHEMBL3476 | O15111 | Inhibitor of nuclear factor kappa B kinase alpha subunit | 84.81% | 95.83% |
CHEMBL3401 | O75469 | Pregnane X receptor | 82.31% | 94.73% |
CHEMBL222 | P23975 | Norepinephrine transporter | 82.26% | 96.06% |
CHEMBL1841 | P06241 | Tyrosine-protein kinase FYN | 82.18% | 81.29% |
CHEMBL1293249 | Q13887 | Kruppel-like factor 5 | 81.84% | 86.33% |
CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 80.12% | 99.17% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
Senegalia berlandieri |
Thymus quinquecostatus |
Thymus vulgaris |